Despite recent efforts to develop mouse models that fully recapitulate human SARS-CoV-2 infection, the current human ACE2 (hACE2)-transgenic mouse model fails to mimic pathogenic progress and symptoms of COVID-19 in humans. This evidence concerns the gene ACE2 and COVID-19.